Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 2/20 | 1.00 |
| ▸ | CYP17A1 | P05093 | 3/20 | 0.59 |
| ▸ | CYP19A1 | P11511 | 3/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.58 |
| ▸ | LMNA | P02545 | 1/20 | 0.58 |
| ▸ | THRB | P10828 | 1/20 | 0.58 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.58 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cedryl Acetate SCHEMBL17409526 | 1.00 | ALOX15 (1.00) | ALOX15CYP17A1CYP19A1ALDH1A1LMNA | |
| Cedryl Acetate SCHEMBL18138231 | 1.00 | ALOX15 (1.00) | ALOX15CYP17A1CYP19A1ALDH1A1LMNA | |
| Cedryl Acetate SCHEMBL27084023 | 1.00 | ALOX15 (1.00) | ALOX15CYP17A1CYP19A1ALDH1A1LMNA | |
| Cedryl Acetate SCHEMBL18604009 | 1.00 | ALOX15 (1.00) | ALOX15CYP17A1CYP19A1ALDH1A1LMNA | |
| Cedryl Acetate SCHEMBL1532502 | 1.00 | ALOX15 (1.00) | ALOX15CYP17A1CYP19A1ALDH1A1LMNA | |
| Cedryl Acetate SCHEMBL8515562 | 1.00 | ALOX15 (1.00) | ALOX15CYP17A1CYP19A1ALDH1A1LMNA | |
| Cedryl Acetate SCHEMBL30392817 | 1.00 | ALOX15 (1.00) | ALOX15CYP17A1CYP19A1ALDH1A1LMNA | |
| Cedryl Acetate SCHEMBL8737981 | 1.00 | ALOX15 (1.00) | ALOX15CYP17A1CYP19A1ALDH1A1LMNA | |
| SCHEMBL8736276 | 0.86 | ALOX15 (0.75) | ALOX15CYP17A1CYP19A1ALDH1A1LMNA | |
| Cedryl Acetate SCHEMBL22498452 | 0.85 | ALOX15 (0.72) | ALOX15CYP17A1CYP19A1ALDH1A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 908 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4637702-A1 | FRAGRANCE COMPOSITIONS AND USES THEREOF | Coty Inc. (US) | 2025-10-29 | — | — | EP | claimed |
| US-20250163343-A1 | FRAGRANCE COMPOSITIONS FOR SLEEP IMPROVEMENT | INTERNATIONAL FLAVORES & FRAGRANCES INC. | 2025-05-22 | — | — | US | claimed |
| US-20250129312-A1 | CONSUMER PRODUCT COMPOSITIONS WITH PERFUME ENCAPSULATES | PROCTER & GAMBLE (US) | 2025-04-24 | — | — | US | claimed |
| US-12209232-B2 | Consumer product compositions with perfume encapsulates | THE PROCTER & GAMBLE COMPANY (US) | 2025-01-28 | — | — | US | claimed |
| EP-4486857-A1 | FRAGRANCE COMPOSITIONS FOR SLEEP IMPROVEMENT | International Flavors & Fragrances Inc. (US) | 2025-01-08 | — | — | EP | claimed |
| CN-119097706-A | Natural product for preventing and treating vascular calcification and application thereof | 江南大学 | 2024-12-10 | — | — | CN | claimed |
| US-20240324588-A1 | ESSENTIAL OIL MICROPARTICLES FOR POWDER COATING APPLICATIONS | Genesee Valley Innovations, LLC | 2024-10-03 | — | — | US | claimed |
| EP-4438065-A2 | A MIXTURE COMPRISING 1,2-ALKANEDIOLS | Symrise AG (DE) | 2024-10-02 | — | — | EP | claimed |
| WO-2024175295-A1 | DETERGENTS AND CLEANING AGENTS COMPRISING DISPERSIN AND FRAGRANCE | HENKEL AG & CO. KGAA (DE) | 2024-08-29 | — | — | WO | claimed |
| EP-4416138-A1 | NOVEL DERIVATIVES OF GLYCEROL | Symrise AG (DE) | 2024-08-21 | — | — | EP | claimed |
| US-20160090555-A1 | CLEANING AND/OR TREATMENT COMPOSITIONS COMPRISING MALODOR REDUCTION COMPOSITIONS | THE PROCTER & GAMBLE COMPANY | 2016-03-31 | — | — | US | claimed |
| US-20160089317-A1 | ANTIPERSPIRANT AND DEODORANT COMPOSITIONS COMPRISING MALODOR REDUCTION COMPOSITIONS | THE PROCTER & GAMBLE COMPANY | 2016-03-31 | — | — | US | claimed |
| US-20160090556-A1 | PRODUCTS COMPRISING MALODOR REDUCTION MATERIALS | THE PROCTER & GAMBLE COMPANY | 2016-03-31 | — | — | US | claimed |
| WO-2016049455-A1 | PERSONAL CARE COMPOSITIONS COMPRISING MALODOR REDUCTION COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2016-03-31 | — | — | WO | claimed |
| WO-2016049407-A1 | ABSORBENT ARTICLE COMPRISING MALODOR REDUCTION COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2016-03-31 | — | — | WO | claimed |
| WO-2016049396-A1 | ANTIPERSPIRANT AND DEODORANT COMPOSITIONS COMPRISING MALODOR REDUCTION COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2016-03-31 | — | — | WO | claimed |
| WO-2016049394-A1 | CLEANING AND/OR TREATMENT COMPOSITIONS COMPRISING MALODOR REDUCTION COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2016-03-31 | — | — | WO | claimed |
| WO-2016049404-A1 | SUBSTRATES COMPRISING MALODOR REDUCTION COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2016-03-31 | — | — | WO | claimed |
| WO-2016049395-A1 | PRODUCTS COMPRISING MALODOR REDUCTION MATERIALS | THE PROCTER & GAMBLE COMPANY (US) | 2016-03-31 | — | — | WO | claimed |
| WO-2016049398-A1 | FRESHENING COMPOSITIONS AND DEVICES COMPRISING SAME | THE PROCTER & GAMBLE COMPANY (US) | 2016-03-31 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160089317-A1 | ANTIPERSPIRANT AND DEODORANT COMPOSITIONS COMPRISING MALODOR REDUCTION COMPOSITIONS | LPO, QDPR, TYR | ALOX15 180/4885CYP17A1 1162/4885CYP19A1 1095/4885 |
| US-20240324588-A1 | ESSENTIAL OIL MICROPARTICLES FOR POWDER COATING APPLICATIONS | EXOSC9, EXOSC4, PHOSPHO1 | ALOX15 41/4885CYP17A1 3208/4885CYP19A1 3884/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.